Sign up to save your podcasts
Or
Share Amazon's Hiring Spree, Pfizer's Controversial COVID Vaccine
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Amazon's Hiring Spree, Pfizer's Controversial COVID Vaccine
In this episode, Shamus Madan discusses Amazon's significant hiring surge and wage policies. He then delves into Pfizer's vaccine development, its market implications, and the skepticism that surrounds its announcement. The episode concludes with closing remarks.
Story #1: Amazon hires over 400,000 employees to keep up with increased demand and holiday sales. The question is will these workers be laid off after demand dies down or after the pandemic?
Story #2: Pfizer’s 90% effective vaccine and what could this mean for the US economy and big tech giants like Amazon, Google, and Apple as they have received more demand during COVID as everyone is at home.
(0:00) Introduction and news highlights
(0:36) Deep dive into Amazon's hiring surge and wage policies
(1:39) Pfizer's vaccine development and its market implications
(2:36) Skepticism surrounding Pfizer's announcement and expert perspectives
(3:36) Conclusion, Disclaimer, and closing remarks
View all episodes
By Shamus Madan
4.6
1717 ratings
In this episode, Shamus Madan discusses Amazon's significant hiring surge and wage policies. He then delves into Pfizer's vaccine development, its market implications, and the skepticism that surrounds its announcement. The episode concludes with closing remarks.
Story #1: Amazon hires over 400,000 employees to keep up with increased demand and holiday sales. The question is will these workers be laid off after demand dies down or after the pandemic?
Story #2: Pfizer’s 90% effective vaccine and what could this mean for the US economy and big tech giants like Amazon, Google, and Apple as they have received more demand during COVID as everyone is at home.
(0:00) Introduction and news highlights
(0:36) Deep dive into Amazon's hiring surge and wage policies
(1:39) Pfizer's vaccine development and its market implications
(2:36) Skepticism surrounding Pfizer's announcement and expert perspectives
(3:36) Conclusion, Disclaimer, and closing remarks
More shows like Clock Speed with Shamus Madan
View all
ACQ2 by Acquired
259 Listeners